Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Xytronyx's immunotherapy shows positive preclinical results

April 24, 1997

Triptorelin + melatonin for prostate cancer

April 23, 1997

Antiangiogenic effects of flavopiridol

April 23, 1997

EntreMed produces recombinant Angiostatin

April 22, 1997

ProScript licenses cell cycle regulation technology from Harvard Medical School

April 22, 1997

ImmunoGen's novel anticancer agent eradicates a human cancer in mice

April 22, 1997

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

Princeton and Lilly disclose nonclassical antifolates

April 22, 1997

Alfacell elucidates action of Onconase

April 22, 1997

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...